Description:

Southwest Oncology Group Registration Form (S0502) NCT00324987 S0502 Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=398EB7EC-7565-1438-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=398EB7EC-7565-1438-E044-0003BA3F9857

Keywords:
Versions (5) ▾
  1. 12/18/14
  2. 1/9/15
  3. 1/9/15
  4. 6/27/15
  5. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Southwest Oncology Group Registration Form (S0502) NCT00324987

No Instruction available.

  1. StudyEvent: Southwest Oncology Group Registration Form (S0502)
    1. No Instruction available.
Header
Patient demographics
Patient Gender
Method of Payment
Patient's Ethnicity
Patient Race (select all that apply)
Miscellaneous Patient Information
My specimens may be kept for use in research to learn about, prevent, treat or cure cancer
My specimens may be kept for research about other health problems
Someone may contact me in the future to ask me to allow other uses of my specimens.
I agree to allow my study doctor, or someone approved by my study doctor, to contact me regard future research involving my participation in this study
I agree to participate in this study of fresh tissue
I agree to participate in this study of blood
Performance status
Disease status

Similar models